Name | Type | Posted | Actions |
|---|---|---|---|
36C24926A0041_1.docx | DOCX | May 26, 2026 |
6550--Roche Ventana IHC/SS Mt Home VAMC Blanket Purchase Agreement Sole Source Notice IAW FAR 12.102(b) Estimated Value
Contact and place of performance
Robert Pitre
Not specified
VHAPG Part 806.3 OFOC Page 1 of 4 Revision: 04 Effective Date: 12/15/25 Acquisition ID#: 36C249-26-AP-1835 DEPARTMENT OF VETERANS AFFAIRS Justification and Approval (J&A) For Other Than Full and Open Competition (>SAT) IAW FAR Overhaul Part 12.102(b) Acquisition Plan Action ID: 36C249-26-AP-1835 Contracting Activity: Department of Veterans Affairs, Network Contracting Office 9 on behalf of VISN 9, James H. Quillen VA...
View moreThe Department of Veterans Affairs, Network Contracting Office 9, has issued a Justification and Approval for a sole source 24-month Blanket Purchase Agreement for the James H. Quillen VA Medical Center in Mountain Home, Tennessee. Identified under solicitation number 36C24926AP1835, this requirement has an estimated value of $880,000 and a performance period from June 1, 2026, to May 30, 2028. The acquisition is classified under NAICS code 325413 In-Vitro Diagnostic Substance Manufacturing and PSC code 6550 IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS.
The scope of this requirement includes the rental of two Roche-VENTANA BenchMark ULTRA PLUS (FS) Immunohistochemical Stainers and one Benchmark Special Stainer for the histology section of the facility's Pathology and Laboratory Medicine Service. This agreement covers all necessary firm-fixed-unit-price consumables, including reagents, stains, and antibodies, as well as technical support and quarterly decontamination services. These products and services are utilized to produce stained slides for pathological evaluation and patient diagnosis. One attachment, a .docx file titled 36C24926A0041_1.docx, was published with the notice on May 26, 2026.
The agency is utilizing the statutory authority for only one responsible source in accordance with 41 U.S.C. 1901. Market research indicates that Roche Diagnostics Corporation is the only vendor capable of providing a staining platform that meets the medical center's workflow and space requirements. The specified equipment allows operators to add or remove slides and reagents through individual drawers without stopping the workflow, a capability that eliminates batch runs and prevents delays in patient tissue staining. Market research further identified multiple recent sole source justifications for similar requirements across the Department of Defense and other government agencies, validating the unique nature of the Roche staining system.
Generated by Lumen AI
Scoped analysis and attachments—go beyond the summary when you need detail from the solicitation package.